| |
|
|
|
ImmunoGen Inc.  
|
|
9.06 -0.18 (-0.02%) |
09-21 16:00 |
|
Open: |
9.2 |
Pre close: |
9.24 |
Target:
|
11.37 
|
|
High: |
9.25 |
Low: |
8.97 |
Resistance:
|
9.73
10.37
|
|
Volume: |
4,578,315 |
Market Cap: |
1348M |
Support:
|
8.70
7.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.97
|
MACD |
MACD(12,26):
|
-0.15  |
|
MA(20): |
9.46 |
Signal(12,26,9): |
-0.11 |
|
MA(100): |
10.05 |
Stochastic Oscillator |
%K(14,3):
|
20.36 |
|
MA(250): |
9.01 |
%D(3): |
16.57 |
|
Average Volume(K) |
3-Month: |
182406
|
52-Week |
High:
|
13.41 |
|
10-Days: |
148153 |
Low: |
4.80 |
|
RSI |
RSI(14):
|
45.02 |
Change(%): |
35.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.070 |
Return on Equity (ttm) |
341.1 |
Shares Out. (M) |
149.02 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-53.0 |
Shares Float (M) |
146.63 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-76.2 |
% Held by Institutions |
79.60 |
|
Forward EPS |
-0.950 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
14355 |
|
Book Value (p.s.) |
15.470 |
EBITDA (p.s.) |
-0.410 |
P/E |
-8.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.59 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-68.76 |
P/S |
2106308608.00 |
|
Operating Margin |
-147.52 |
Levered Free Cash Flow
(M) |
-72.68 |
P/CF |
-19.64 |
|
|
|
|
|
|
